{
    "nct_id": "NCT06023576",
    "official_title": "Intensive Blood Pressure Control During Cardiotoxic Breast Cancer Treatment (PROTECT), A Randomized Controlled Trial",
    "inclusion_criteria": "* Age ≥ 18 years\n* Female assigned at birth\n* Biopsy proven breast cancer (stage I-IV)\n* Treatment with therapy anthracycline-based chemo (with or without HER2-targeted therapy), with >/= 2 cycles of anthracycline chemotherapy planned.\n* SBP ≥130 mm Hg\n* Willing and able to comply with the requirements of the protocol.\n* Participant must have and be willing to use their bluetooth enabled wifi or cellular mobile device\n* (For participants in the CPET cohort): Able to complete an acceptable baseline CPET, in the absence of high-risk ECG findings or other inappropriate response to exercise as determined by the PI, as defined by any of the following criteria:\n\n  * Achieving a plateau oxygen consumption, concurrent with an increase in power output;\n  * A respiratory exchange ratio ≥ 1.10;\n  * Attainment of maximal predicted heart rate, as defined by a peak heart rate within 10bpm of the age predicted maximal heart rate (220 - Age[years]);\n  * Volitional exhaustion, as measured by a rating of perceived exertion (RPE) ≥ 18 on the BORG scale.\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* eGFR < 30 ml/min/1.73m2 (based upon Cockcroft-Gault, etc.)\n* Individuals with arm circumference too large to allow accurate BP measurement with available BP devices\n* Inability to accurately measure blood pressure in at least one arm (e.g., bilateral upper extremity lymphedema)\n* Cardiac comorbidity, including any of the following:\n\n  * Acute coronary syndrome within 3 months prior to randomization.\n  * Symptomatic heart failure (NYHA class III/IV) within past 6 months\n  * History of stroke\n  * Cardiac transplantation\n* Other medical disorder or condition that in the opinion of the investigator would impair the subject's ability to participate or adhere to study interventions\n* (For participants in the CPET cohort): Subjects must not have any of the following absolute contraindications to cardiopulmonary exercise testing:\n\n  * Acute myocardial infarction (within 30 days of any planned study procedures),\n  * Unstable angina\n  * Uncontrolled arrhythmias causing symptoms or hemodynamic compromise,\n  * Symptomatic severe aortic stenosis\n  * Recurrent syncope\n  * Active endocarditis\n  * Acute myocarditis or pericarditis\n  * Acute pulmonary embolus or pulmonary infarction (within 3 months of any planned study procedures)\n  * Thrombosis of lower extremities (within 3 months of any planned study procedures)\n  * Suspected dissecting aneurysm\n  * Uncontrolled asthma\n  * Pulmonary edema\n  * Room air desaturation at rest ≤85%\n  * Respiratory failure\n  * Acute noncardiopulmonary disorder that may affect exercise performance or be aggravated by exercise (i.e., infection, renal failure, thyrotoxicosis)\n  * Mental impairment leading to inability to cooperate.",
    "miscellaneous_criteria": ""
}